Agena Bioscience Opens Office in Shanghai
News Sep 04, 2015
“The Chinese market represents a significant portion of Agena Bioscience’s global sales with almost sixty MassARRAY® Systems installed to date. Direct presence within China will allow us to expand our reach and foster a high degree of engagement with our local customers in that region,” said Pete Dansky, CEO.
Bob Wang has joined Agena Bioscience as its Vice President and General Manager, Greater China. Bob most recently was Marketing Director for QIAGEN, responsible for leading the development of its molecular diagnostics and life science commercial strategies. Prior to this, Bob held senior positions encompassing Business Development, Marketing, Sales, and Regulatory Affairs at Hologic, Life Technologies, Applied Biosystems, and the Chinese Human Genome Center.
“We are delighted to have Bob leading our Greater China organization. His experience in both clinical diagnostics and life science research will help drive Agena Bioscience’s strategy and commercial execution in China,” said Dansky.
The MassARRAY System by Agena BioscienceTM provides a mid-plex technology for targeted profiling of 10’s to 100s of genetic markers. The system offers a practical solution for today’s clinical and translational research labs with improvements in cost, throughput, reimbursement, and ease of use over alternative methods. The MassARRAY System is used in 37 countries worldwide with an installed base of 350+ systems.
Agilent Obtains U.S. FDA Approval for GenetiSure Dx Postnatal AssayNews
Agilent Technologies has obtained 510(k) clearance from the FDA for the GenetiSure Dx Postnatal Assay: its first comparative genomic hybridization (CGH) assay for diagnostic use.READ MORE
New Tech Enables Loading of DNA Into Sequencing Wells With Orders of Magnitude Higher EfficiencyNews
A Northeastern research team has developed new technology that optimizes DNA sequencing using nanophysics and electric currents.READ MORE
Rare Genetic Variant May Play Key Role in SchizophreniaNews
Professor Toshihide Yamashita said" RTN4 is a promising candidate gene for schizophrenia because it is located at chromosome 22q11.2, a hotspot for schizophrenia”.READ MORE